Laura Evgin
  • Center for Innovative Cancer Research, Ottawa Hospital Research Institute, Canada
研究方向
  • Cancer biology
个人信息

Education

Ph.D., University of Ottawa, Canada

Current position

Post-doctoral fellow, Mayo Clinic, Minnesota, USA

Publications

  1. Evgin, L., Acuna, S. A., Tanese de Souza, C., Marguerie, M., Lemay, C. G., Ilkow, C. S., Findlay, C. S., Falls, T., Parato, K. A., Hanwell, D., Goldstein, A., Lopez, R., Lafrance, S., Breitbach, C. J., Kirn, D., Atkins, H., Auer, R. C., Thurman, J. M., Stahl, G. L., Lambris, J. D., Bell, J. C. and McCart, J. A. (2015). Complement inhibition prevents oncolytic vaccinia virus neutralization in immune humans and cynomolgus macaques. Mol Ther 23(6): 1066-1076.
  2. Muharemagic, D., Zamay, A., Ghobadloo, S. M., Evgin, L., Savitskaya, A., Bell, J. C. and Berezovski, M. V. (2014). Aptamer-facilitated Protection of Oncolytic Virus from Neutralizing Antibodies. Mol Ther Nucleic Acids 3: e167.
  3. Parato, K. A., Breitbach, C. J., Le Boeuf, F., Wang, J., Storbeck, C., Ilkow, C., Diallo, J. S., Falls, T., Burns, J., Garcia, V., Kanji, F., Evgin, L., Hu, K., Paradis, F., Knowles, S., Hwang, T. H., Vanderhyden, B. C., Auer, R., Kirn, D. H. and Bell, J. C. (2012). The oncolytic poxvirus JX-594 selectively replicates in and destroys cancer cells driven by genetic pathways commonly activated in cancers. Mol Ther 20(4): 749-758.
  4. Breitbach, C. J., Burke, J., Jonker, D., Stephenson, J., Haas, A. R., Chow, L. Q., Nieva, J., Hwang, T. H., Moon, A., Patt, R., Pelusio, A., Le Boeuf, F., Burns, J., Evgin, L., De Silva, N., Cvancic, S., Robertson, T., Je, J. E., Lee, Y. S., Parato, K., Diallo, J. S., Fenster, A., Daneshmand, M., Bell, J. C. and Kirn, D. H. (2011). Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans. Nature 477(7362): 99-102.
  5. Breitbach, C. J., De Silva, N. S., Falls, T. J., Aladl, U., Evgin, L., Paterson, J., Sun, Y. Y., Roy, D. G., Rintoul, J. L., Daneshmand, M., Parato, K., Stanford, M. M., Lichty, B. D., Fenster, A., Kirn, D., Atkins, H. and Bell, J. C. (2011). Targeting tumor vasculature with an oncolytic virus. Mol Ther 19(5): 886-894.
  6. Evgin, L., Vaha-Koskela, M., Rintoul, J., Falls, T., Le Boeuf, F., Barrett, J. W., Bell, J. C. and Stanford, M. M. (2010). Potent oncolytic activity of raccoonpox virus in the absence of natural pathogenicity. Mol Ther 18(5): 896-902.